Stocks-TRVN-Trevena Inc

TRVN Trevena Inc

3.30 -0.15 (-4.48%)
in USD Market Open
Invest

Overview

Prev Close3.46
Day's Range 3.31 - 3.40
52 Week Range 2.27 - 18.93
Average Volume (3m)42.95K
1-Year Return-80.18%
Beta1.0714
Market Cap26.69M
P/E Ratio
Revenue-419K
EPS-9.0955
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Industry Pharmaceuticals Major
CEO Carrie L. Bourdow, MBA
Employees 43

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Trevena Inc's revenues decreased by 81.52% and amounted to 567.00K. Net income decreased by 75.65% to -51.59M. Net assets decreased by 37.90% to 64.63M and EPS decreased from -0.23 to -0.32.
TRVN's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
-813.50%
Net Profit Margin
-18,164.29%
Operating Margin
-29,583.00%
Return On Investment
-74.76%
12/21
03/22
06/22
09/22
Total Revenue
-1K
20K
0
-438K
Gross Profit
-550K
-406K
-439K
-3.02M
Operating Income
-14.03M
-16.46M
-14.81M
-15.76M
Net Income
-13.95M
-16.39M
-14.98M
-15.3M